HTML Ready Article. Click on the "Copy" button to copy into your clipboard.

PBX Phone System Market In Good Health

By: Stuart Boardman

The introduction of new technology specifically aimed at improving PBX systems has brought the potential for tremendous sales growth in providing such systems for business landlines.

That's according to Phil Adams, Systems Sales Director at Nimans and Rocom, who has told CommsBusiness that resellers, manufacturers and distributors had all been viewing the market's prospects more positively since the start of the year.

A PBX, or private branch exchange, system is the traditional entry-level solution for business phone lines. It automatically selects an available line from which an outgoing call can be made. He said he believed there were signs that the worst days of the current market were nearly over, and that 2010 would present great potential for proactive resellers, something all businesses are hoping for.

Manufacturers were still keen to focus their innovations on this sector because, Adams added, this was where there was the greatest proportion of potential new business to be found. The days when the more sophisticated solutions were reserved for the bigger market sectors, he said.

The need for even smaller businesses of 10 or 15 staff to maximise the potential of open communications systems means that developments among companies serving this sector are running at a much faster pace than any other area of the market.

And managers of such SMEs were demanding the latest innovations in their phone systems, because the technology could potentially bring their business far greater benefits relative to the costs involved than was the case with larger companies, because technology could make a huge difference to their bottom line, he said.

This was the key criterion which would persuade a smaller company to review and possibly upgrade their business phone lines, and demonstrating that a good return on their investment was vital in that effort.

Resellers focusing on serving the market for businesses with fewer than 25 staff had withstood the recession better than any others in the sector, Adams concluded. Such companies had learned the importance of understanding their customers and showing them how investing in modern communications systems can impact positively on their bottom line.

A business phone line from Daisy can save a company at least 10 per cent in its ongoing line rental costs. For example, a company could pay as little as GBP 13.38 a month. Switching providers is no hassle, as Daisy will take care of all the work involved in transferring a system to a new provider.

Author Resource:->  If you are looking for ways to improve the efficiency and communication of your company then visit http://www.daisyplc.com/ for the best deals around.

Article From Articles Free UK

Firefox users please select/copy/paste as usual From The New York Times: Journal Retracts 1998 Paper Linking Autism to Vaccines

The article discusses some of the background on the original research led by Andrew Wakefield that was published in The Lancet, additional research efforts to confirm a potential link between the MMR vaccine and autism, and potential ethical concerns with the original research.

I found this particular sequence in the article to be particularly interesting:

Jim Moody, a director of SafeMinds, a parents’ group that advances the notion the vaccines cause autism, said the retraction would strengthen Dr. Wakefield’s credibility with many parents.

“Attacking scientists and attacking doctors is dangerous,” he said. “This is about suppressing research, and it will fuel the controversy by bringing it all up again.

I was talking about this in the office a couple days ago, and the conversation was about whether or not this retraction will matter. My initial reaction is that it won't - the people who believe there is a link between the MMR vaccine and autism aren't likely to be swayed by the retraction of this article. Indeed, it may strengthen their conviction that the government/academia/big pharma are trying to bury the truth.

This article reminds me of a NPR Science Friday that was on probably a couple months ago. They had a vaccine expert on talking about this, and a parent called in who believed there was a MMR vaccine-autism link. The vaccine expert explained his view of the science and facts. The parent said he wasn't right. At some point (because he's a good host) Ira Flatow asked the caller if there was anything the vaccine expert could say that would change her mind. The caller thought for a moment, then replied (IMHO) honestly: "Probably not."

I don't know that this is something I'm going to dig into myself, but there's an interesting study here - particularly if you have pre-data on people's opinions of the MMR vaccine-autism link or we can assume that plenty of people never heard about the retraction (probably a safe bet) to do a pre/post survey to see what impact it has on people's opinions.